Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPOND: Ticagrelor vs Clopidogrel in Stable Coronary Artery Disease Patients Identified as Clopidogrel Responders or Non-responders
2008-005305-19Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ticagrelor in coronary arteriosclerosis (2 arms), sponsored by AstraZeneca. Started Sep 2008; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-005305-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005305-19.